Weight Loss without Food Intake Suppression through Size-Dependent Retention of Anti-Inflammatory Nanomedicines
ACS Nano · 2026
DOI: 10.1021/acsnano.6c00432 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, 2026. Verfasst von Natalia Gonzalez Medina und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, University of Illinois Urbana-Champaign, Urbana, Illinois61801, United States. Hauptthemen laut MEDLINE: Weight Loss, Nanomedicine, Obesity, Anti-Inflammatory Agents. Die Arbeit nennt 81 Literaturangaben. Gefördert von: National Science Foundation, National Institutes of Health (NIH).
Abstract (Originalsprache)
Obesity is a risk factor for high-mortality health conditions, including cardiovascular diseases and type 2 diabetes, which makes the advancement of efficacious and safe weight loss therapies a high priority in pharmacology. The causal link between obesity and its comorbid conditions is believed to be a chronic state of inflammation originating within adipose tissue, with macrophages playing central roles, an axis that is not targeted directly by current therapies. Here, we use nanocarriers to deliver an anti-inflammatory glucocorticoid receptor agonist to adipose tissue macrophages and report the impact of size on therapeutic effect. Three dextran nanocarriers between 4–30 nm in hydrodynamic diameter released molecular drug cargo at equivalent rates and exhibited similar biological potency in vitro. In vivo in a mouse model of obesity, body weight and body fat were reduced in a size-dependent manner after 2–4 weeks of treatment. Unlike current clinical pharmacotherapies for weight loss, these body composition changes were not associated with changes in food intake. Greater retention of larger dextran nanocarriers in visceral adipose tissue appears to elicit a local change to promote browning by increasing mitochondrial abundance and lipid droplet fragmentation. Further development of this platform may result in a safe and potent modulator of adipose tissue in the state of obesity without direct action on nutrient intake to address malnutrition and lean body mass deficiencies observed with current weight loss pharmacotherapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bioengineering, University of Illinois Urbana-Champaign, Urbana, Illinois61801, United States.
- Holonyak Micro and Nanotechnology Laboratory, University of Illinois Urbana-Champaign, Urbana, Illinois61801, United States.
- Department of Materials Science and Engineering, University of Illinois Urbana-Champaign, Urbana, Illinois61801, United States.
- Department of Chemical and Biomolecular Engineering, University of Illinois Urbana-Champaign, Urbana, Illinois61801, United States.
- Cancer Center at Illinois, University of Illinois Urbana-Champaign, Urbana, Illinois61801, United States.
- Carl R. Woese Institute for Genomic Biology, University of Illinois Urbana-Champaign, Urbana, Illinois61801, United States.
ORCID-Profile: Natalia Gonzalez Medina, Donglai Chen, Muhammad Fayyaz, Andrew M Smith
Förderung
- National Science Foundation
- National Institutes of Health (NIH)
Zitieren
APA
Medina, N. G., Cui, Y., Chen, D., Fayyaz, M., Xu, F., Mirshafeeyan, M., & Smith, A. M. (2026). Weight Loss without Food Intake Suppression through Size-Dependent Retention of Anti-Inflammatory Nanomedicines. ACS Nano. https://doi.org/10.1021/acsnano.6c00432
Vancouver
Medina NG, Cui Y, Chen D, Fayyaz M, Xu F, Mirshafeeyan M, et al. Weight Loss without Food Intake Suppression through Size-Dependent Retention of Anti-Inflammatory Nanomedicines. ACS Nano. 2026. doi:10.1021/acsnano.6c00432
BibTeX
@article{Medina2026,
author = {Medina, Natalia Gonzalez and Cui, Yuxiao and Chen, Donglai and Fayyaz, Muhammad and Xu, Fengyuan and Mirshafeeyan, Mahshad and Smith, Andrew M},
title = {Weight Loss without Food Intake Suppression through Size-Dependent Retention of Anti-Inflammatory Nanomedicines},
journal = {ACS Nano},
year = {2026},
doi = {10.1021/acsnano.6c00432}
}
EUVIMED